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OBJECTIVE — African American youth have lower insulin sensitivity than their Caucasian
peers, but the metabolic pathways responsible for this difference remain unknown. Free fatty
acids (FFAs) are associated with insulin resistance through the Randle cycle. The present inves-
tigation determined whether elevating FFA is more deleterious to insulin sensitivity in African
American than in Caucasian adolescents.
RESEARCH DESIGN AND METHODS — Insulin sensitivity (3-h hyperinsulinemic-
euglycemic clamp) was evaluated in 22 African American and 21 Caucasian adolescents on two
occasions: 1) infusion of normal saline and 2) infusion of 20% intralipid.
RESULTS — During intralipid infusion, fasting insulin and C-peptide concentrations in-
creased while fasting glucose and basal glucose turnover did not change in either group. Insulin
sensitivity decreased similarly in African American (normal saline 7.65  0.61 vs. intralipid
5.150.52mol kg
1 min
1perpmol/l)andCaucasiansubjects(normalsaline8.970.85
vs. intralipid 5.96  0.56 mol   kg
1   min
1 per pmol/l) (P  0.001).
CONCLUSIONS — African American and Caucasian adolescents respond to FFA elevation
similarlythroughincreasedfastinginsulinsecretiontomaintainfastingglucosehomeostasisand
reduced peripheral glucose uptake and insulin resistance. Thus, African American adolescents
are not more susceptible to FFA-induced insulin resistance than Caucasian youth.
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F
ree fatty acids (FFAs) are implicated
in insulin resistance development
through the Randle cycle (1,2). In
adults, elevating plasma FFA by infusing
lipid emulsion inhibits glucose disposal
and oxidation in normal-weight, obese,
and type 2 diabetic patients (3–5). The
only pediatric study was performed in
Caucasian children and demonstrated
that intralipid infusion decreased insulin
sensitivity in pubertal adolescents, with
nosucheffectinprepubertalchildren(6).
Such data support that pubertal insulin
resistance is driven by the Randle cycle/
substrate competition (7,8).
Insulin sensitivity is lower in African
American children than in their Cauca-
sian peers (9,10), but the metabolic path-
ways responsible for this contrast remain
unknown. Lower insulin sensitivity cor-
relates inversely with an increased fat-to-
carbohydrate ratio in the diet of African
American children (10,11). Thus, FFAs
may be detrimental to insulin sensitivity
in African American children. If race-
related differences in the susceptibility to
FFA-induced insulin resistance exist,
then this is of increased importance dur-
ing puberty when increased FFAs de-
crease glucose disposal (6). The present
investigation, therefore, aimed to com-
paretheeffectsofFFAelevationonfasting
and insulin-stimulated glucose metabo-
lism in African American and Caucasian
adolescents. We hypothesized that in-
creased concentrations of circulating
FFAs result in a greater decrement in in-
sulin sensitivity in African American than
in Caucasian adolescents.
RESEARCH DESIGN AND
METHODS— Twenty-two African
American and twenty-one Caucasian ad-
olescents, recruited through advertise-
ments, participated in this study at the
Pediatric Clinical and Translational Re-
searchCenterofChildren’sHospitalPitts-
burgh after institutional review board
approval. Participants and their parents
gave written informed consent. Partici-
pants were in good health as assessed by
medical history, physical examination,
and hematological and biochemical tests
(Table 1). All participants were in Tanner
stages II–V of puberty and were weight
stable before study entry. None were di-
eting, and none were receiving medica-
tions including contraceptive pills. Total
bodycompositionandabdominaladipos-
itywereassessedbydual-energyX-rayab-
sorptiometryandcomputedtomography,
respectively, as previously described by
us (10).
Study design
Participantsmaintainedfree-livingcondi-
tions during the experimental period.
None took part in organized sports. We
prescribed a weight-maintaining diet
containing 55% carbohydrate, 30% fat,
and 15% protein during the investiga-
tions. Each participant undertook a 3-h
hyperinsulinemic-euglycemic clamp on
two occasions after an overnight fast dur-
ing infusion of normal saline or infusion
of 20% intralipid in random order and
1–2 weeks apart.
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catheter was inserted into a forearm vein
for administration of test infusions and a
secondinaveinofthecontralateralhand,
after being heated, for sampling of arteri-
alized venous blood (8). After blood sam-
ples were obtained at 0700 h (180 min
from start of hyperinsulinemic-
euglycemic clamp), a primed (2.2 mol/
kg), constant infusion of [6, 6-
2H2]
glucose (0.22 mol   kg
1   min
1) was
administered from 0700 to 1300 h (6). At
0700 h, either a triglyceride emulsion of
20% intralipid (20% soybean oil, 1.2%
egg yolk phospholipids, and 2.25% glyc-
erol; Kabi Pharmacia, Clayton, NC) or
0.9% saline was infused at 0.02 ml   kg
1
  min
1 until 1300 h. Blood was sampled
at 180 min and every 10 min from 30
to 0 min (basal period) for determination
of plasma glucose, insulin, C-peptide,
FFA, and isotopic enrichment. Plasma
triglyceridesweredeterminedat30and
0 min of the basal infusion period.
After basal evaluation (0700–1000
h), insulin-stimulated glucose metabo-
lism was investigated by a 3-h hyperinsu-
linemic-euglycemic clamp (8) starting at
1000 h. Intravenous crystalline insulin
(Humulin;Lilly,Indianapolis,IN)wasin-
fused at a constant rate of 40 mU/m
2 per
min for 3 h. Plasma glucose was clamped
at5.5mmol/lwithavariablerateinfusion
of 20% dextrose, enriched with [6,
6-
2H2]glucose (6). The glucose infusion
rate was adjusted based on arterialized
plasma glucose measurements every 5
min. Blood was sampled every 10 min
over the last 30 min of the clamp (150–
180 min) for determination of insulin,
FFA, and isotope enrichment. Triglycer-
idesweredeterminedat150and180min
of the clamp.
For each condition, indirect calorim-
etry was performed using a ventilated
hood system (Deltatrac Metabolic Moni-
tor; Sensormedics, Anaheim, CA) for a
30-min period before starting (30 to 0
min)(basalperiod)andendingthe(150–
180 min) clamp (6). Urine was collected
overnight from 2300 h until 0700 h for
urinary nitrogen measurement for calcu-
lation of baseline substrate oxidation and
from 0700 h until 1300 h for calculating
substrate oxidation during the clamp.
Biochemical measurements
At each sampling point, blood samples
were placed immediately on ice and
plasma was separated within 15 min in a
refrigerated centrifuge. Plasma samples
were divided into aliquots and stored at
80°C until analysis. Plasma glucose was
measured by the glucose oxidase method
using a glucose analyzer (Yellow Springs
Instruments, Yellow Springs, OH).
Plasma insulin and C-peptide were deter-
mined by radioimmunoassay (12). Enzy-
matic colorimetric methods were used to
determine FFA (Wako nonesteriﬁed fatty
acid [NEFA] C test kit; Wako, Osaka, Ja-
pan)andtriglycerideconcentrations.Uri-
nary nitrogen was measured by the
Kjeldahl method (8). Deuterium enrich-
ment of plasma glucose was determined
on a gas chromatography mass spectrom-
eter (model 5985A; Hewlett Packard,
Palo Alto, CA) (6,13). Standard curves of
knownenrichmentswereperformedwith
each assay.
Calculations
Basal rate of appearance of endogenous
glucose in the plasma or hepatic glucose
production was calculated during the last
30minofthepostabsorptiveperiod(30
to 0 min) using steady-state tracer dilu-
tion equations (8). Under basal condi-
tions, rate of appearance equals glucose
rate of disposal (Rd). Calculations were
made over the last 30 min of the 3-h
clamp (150–180 min) for insulin sensi-
tivity and clearance (6,10).
Basal and insulin-stimulated sub-
strate oxidation rates were calculated
from indirect calorimetric data during
each period (14). Basal and insulin-
stimulated nonoxidative glucose Rd was
estimated by subtracting the rate of glu-
cose oxidation from the total Rd during
thelast30minofthebasalperiod(30to
0 min) and clamp (150–180 min).
Statistical analysis
Statistics were analyzed using SPSS 15.0
for Windows. Based on our previous data
(6,10), the current study was powered
(80% power with 22 participants in each
group) to test the primary hypothesis that
the decrement in insulin sensitivity with
intralipid infusion would be 60% greater
in African American adolescents than in
Caucasian adolescents. A 2  2 mixed
ANOVA (repeated measures within sub-
jects based on factor of condition, i.e.,
normal saline vs. intralipid; between sub-
jects based on factor of race, i.e., African
Americanvs.Caucasian;andcondition
race interaction) was used to analyze glu-
cose; insulin; C-peptide; triglycerides;
FFAs; fat oxidation; total, oxidative, and
nonoxidative glucose disposal; and insu-
lin sensitivity. Sex-related differences
were analyzed with a 2  2 mixed
ANOVA (repeated measures within sub-
jects based on factor of condition, i.e.,
normal saline vs. intralipid; between sub-
jects based on factor of sex, i.e., male vs.
female; and condition  sex interaction),
combining African American and Cauca-
sian data. Data are presented as means 
SEM with signiﬁcance set at P  0.05.
Table 1—Physical and biochemical characteristics of the participants
African
American Caucasian P
n 22 21
Age (years) 13.3  0.2 13.9  0.3 0.09
Sex (male/female) 11/11 13/8 0.43
Family history of type 2 diabetes (/) 16/6 10/11 0.09
Tanner stage
II–III 8 9 —
IV–V 14 12 —
Height (cm) 159.8  2.1 163.3  2.1 0.25
Weight (kg) 58.7  2.5 61.4  3.5 0.53
BMI (kg/m
2) 22.9  0.7 22.8  1.0 0.97
BMI percentile 72.8  5.6 68.3  6.3 0.59
Fat mass (kg) 13.9  1.7 15.8  2.2 0.50
Body fat % 23.6  2.2 25.4  2.5 0.61
Visceral adipose tissue (cm
2) 26.2  3.5 37.7  4.6 0.052
Subcutaneous adipose tissue (cm
2) 131.7  17.8 187.2  26.8 0.09
Testosterone (nmol/l)* 11.7  2.2 13.6  2.2 0.56
Estradiol (pmol/l)* 93  19 88  18 0.87
A1C (%) 5.2  0.1 5.2  0.1 0.85
DataaremeansSEMunlessotherwiseindicated.Sexandfamilyhistoryoftype2diabetescomparedusing

2 analysis. All other variables compared using an independent Student’s t test. *Testosterone in males only
and estradiol in females only.
FFA and insulin sensitivity in African American youth
356 DIABETES CARE, VOLUME 32, NUMBER 2, FEBRUARY 2009RESULTS
Basal period
Hormone and substrate concentrations
during the ﬁnal 30 min of the baseline
period are presented in Table 2 and
Fig.1. Insulin, C-peptide, and triglycer-
ideconcentrationsallincreasedwithin-
tralipid infusion (main effect of
condition for all variables; P  0.001)
(Table 2, Fig. 1C) with no differences
between African American and Cauca-
sianadolescents.ConcentrationsofFFA
signiﬁcantly increased with intralipid
infusion (main effect of condition; P 
0.001) (Fig. 1A) and, overall, were sig-
niﬁcantly higher in African American
than in Caucasian subjects (main effect
of race;P  0.010). The increase in FFA
concentrations between conditions was
greater in African American than in
Caucasian subjects (condition  race
interaction; P  0.016). Despite higher
FFAs with intralipid infusion, there
were no differences in fasting glucose
concentrations between conditions and
no differences between African Ameri-
can and Caucasian subjects (Table 2).
Fat oxidation was signiﬁcantly greater
with intralipid infusion (main effect of
condition; P  0.001) (Fig. 1B). Over-
all, fat oxidation was greater in Cauca-
sian than in African American subjects
(main effect of race; P  0.008). Oxida-
tive glucose disposal decreased with in-
tralipid infusion (main effect of
condition;P  0.001),whereasnonoxi-
dative glucose disposal increased (main
effect of condition; P  0.012) (Fig.
1D),withnodifferencebetweenAfrican
American and Caucasian subjects.
Table 2—Hormone and substrate concentrations during the last 30 min of the 3-h baseline period in the normal saline vs. intralipid infusion
conditions
African American Caucasian P
Normal
saline Intralipid
Normal
saline Intralipid Condition Race Interaction
Glucose (mmol/l) 5.25  0.05 5.27  0.06 5.35  0.09 5.40  0.07 0.340 0.198 0.728
C-peptide (nmol/l) 0.66  0.04 0.86  0.06 0.73  0.05 0.93  0.06 0.001 0.364 0.878
Triglycerides (mmol/l) 0.93  0.08 5.42  0.35 1.32  0.20 6.03  0.64 0.001 0.219 0.162
Data are means  SEM.
Figure 1—FFA concentration (A), fat oxidation (B), insulin concentration (C), and glucose rate of appearance (Ra) (D) in African American (AA)
(n  22) and Caucasian (AW) (n  21) adolescents during infusion of normal saline (NS) (empty bars) or 20% intralipid (IL) (ﬁlled bars) in the
ﬁnal 30 min of the baseline postabsorptive period. D: Hatched bars represent glucose oxidation, and blank bars represent nonoxidative glucose
disposal.
aMain effect of condition, normal saline vs. intralipid (P  0.05).
bMain effect of race, African American vs. Caucasian (P  0.05).
cCondition  race interaction (P  0.05).
Burns and Associates
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Hormone and substrate concentrations
during the ﬁnal 30 min of the hyperinsu-
linemic-euglycemic clamp are presented
in Table 3 and Fig. 2. Steady-state plasma
glucose and insulin concentrations did
not differ between conditions or groups
during the clamp (Table 3). Mean within-
subject coefﬁcient of variation of blood
glucose during the clamp was 3.6 
1.8%. Plasma triglyceride concentrations
were signiﬁcantly greater with intralipid
infusion but did not differ overall be-
tween the African American and Cauca-
sianadolescents.However,theincreasein
plasma triglyceride concentrations be-
tween conditions was greater in African
American than Caucasian subjects (con-
ditionraceinteraction;P0.028)(Ta-
ble 3). FFA concentrations (main effect of
condition; P  0.001) (Fig. 2A) and fat
oxidation (main effect of condition; P 
0.001) (Fig. 2B) were increased with in-
tralipid, but there was no difference be-
tween African American and Caucasian
subjects. Both oxidative (main effect of
condition;P  0.001)andnonoxidative
(main effect of condition; P  0.001)
glucose disposal decreased with in-
tralipid infusion, with the changes sim-
ilar between the African American and
Caucasian groups (Fig. 2C). Insulin
sensitivity was lower during intralipid
infusion (main effect of condition; P 
0.001), but the change in insulin sensi-
tivity between conditions did not differ
between the African American and Cau-
casian youth (Fig. 2D).
Sex-related differences were analyzed
combining African American and Cauca-
sian data. During intralipid infusion, in-
sulin sensitivity declined signiﬁcantly in
both female (normal saline 7.95  0.56
vs. intralipid 4.73  0.38 mol   kg
1  
min
1 per pmol/l) and male subjects
(normal saline 8.58  0.83 vs. intralipid
6.20  0.59 mol   kg
1   min
1 per
pmol/l; main effect of condition, P 
0.001), with no sex differences. Both ox-
idative (main effect of condition; P 
0.001) and nonoxidative (main effect of
Table3—Hormoneandsubstrateconcentrationsduringthelast30minofthe3-hhyperinsulinemic-euglycemicclampduringnormalsalinevs.
intralipid infusion
African American Caucasian P
Normal saline Intralipid Normal saline Intralipid Condition Race Interaction
Glucose (mmol/l) 5.57  0.02 5.57  0.03 5.61  0.03 5.59  0.02 0.689 0.193 0.848
Insulin (pmol/l) 676.9  27.7 688.4  24.4 606.4  25.0 650.2  24.8 0.130 0.091 0.373
Triglycerides (mmol/l) 0.65  0.06 6.17  0.44 1.12  0.22 6.93  0.94 0.001 0.190 0.028
Data are means  SEM.
Figure2—FFAconcentration(A),fatoxidation(B),insulin-stimulatedglucosedisposal(Rd),andinsulinsensitivity(D)inAfricanAmerican(AA)
(n  22) and Caucasian (AW) (n  21) adolescents during infusion of normal saline (NS) (empty bars) or 20% intralipid (IL) (ﬁlled bars) in the
ﬁnal 30 min of the 3-h hyperinsulinemic-euglycemic clamp. C: Hatched bars represent glucose oxidation, and blank bars represent nonoxidative
glucose disposal.
aMain effect of condition, normal saline vs. intralipid (P  0.05).
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decreased signiﬁcantly with intralipid in-
fusion, but there was no difference be-
tween male and female adolescents.
Concentrations of FFA increased signiﬁ-
cantly with intralipid in both male (nor-
mal saline 0.04  0.00 vs. intralipid
1.64  0.18 mmol/l) and female (normal
saline 0.03  0.00 vs. intralipid 1.34 
0.10 mmol/l; main effect of condition,
P  0.001) subjects and were similar be-
tween sexes.
CONCLUSIONS — We hypothe-
sized that increasing FFA concentrations
results in a greater decrement in insulin
sensitivity in African American than in
Caucasianadolescents.Thiswasbasedon
observationsthatAfricanAmericanyouth
havelowerinsulinsensitivitythanCauca-
sian youth (9,10) and that an increased
fat-to-carbohydrate ratio in the diet of Af-
rican American youth correlates nega-
tively with insulin sensitivity and
clearance(10,11)andpositivelywithfast-
ing FFA and insulin secretion (10). Con-
trary to our hypothesis, we found that
FFA-induced insulin resistance is similar
betweenAfricanAmericanandCaucasian
adolescents.Itdoesnotappear,therefore,
that the glucose–fatty acid (Randle) cycle
(1) explains insulin sensitivity differences
between African Americans and Cauca-
sians. A number of secondary observa-
tions from this study, however, deserve
brief elaboration. Some caution is re-
quired in interpreting these secondary
observations because our study was not
powered to test them.
Thepresentstudyistheﬁrsttoexamine
race-related differences in susceptibility to
FFA-induced insulin resistance. Consistent
with adult studies (3–5) and our prior pe-
diatric investigation examining the Randle
cycle (6), we found decreased insulin-
stimulated glucose disposal and induction
of insulin resistance with intralipid infu-
sion. In addition, the present study and our
previous pediatric investigation found that
intralipid infusion did not alter basal glu-
coseturnoverorconcentration.Rather,FFA
elevation resulted in increased fasting insu-
lin and C-peptide concentrations in both
African American and Caucasian adoles-
cents—a ﬁnding consistent with FFA’s
short-term stimulatory effect on insulin se-
cretioninCaucasianadults(15).Becauseof
the supraphysiological levels of FFAs
achieved with intralipid infusion, the rele-
vance of these ﬁndings may be limited to
extremely insulin-resistant or hyperinsu-
linemic subjects with hypertriglyceridemia.
During the baseline period, intralipid
infusion resulted in a greater increase in
plasma FFA concentrations in African
American than in Caucasian subjects.
Whetherthelowerfatoxidationobserved
in the African American group during the
postabsorptive period could potentially
explain that group’s greater increase in
FFA levels cannot be surmised from the
current data. Our study design did not
completelycontrolfortheantecedentdiet
and physical activity of the participants,
factors which inﬂuence postabsorptive
substrate oxidation. Therefore, between-
group differences in fat oxidation cannot
beconﬁdentlyattributedtoethnicfactors.
Despite higher FFA concentrations in the
African American group, however, glu-
cose turnover was similar at baseline be-
tween the two groups of adolescents.
We did not ﬁnd any sex differences
with intralipid-induced insulin resis-
tance. Previous adult studies examining
sex-related differences in FFA-induced
insulin resistance are disparate (16–18).
One study (16) found that FFA elevation
signiﬁcantlydecreasedinsulin-stimulated
totalandnonoxidativeglucosedisposalin
men, with no change in women. Con-
versely, another study (17), with similar
conditions and participants, found FFA-
impaired glucose disposal in women. In-
sulin sensitivity was not reported,
however, in either study. A recent inves-
tigation (18) comparing obese male and
female subjects found glucose disposal
similar between sexes with intralipid in-
fusion but found insulin sensitivity lower
in male than in female participants. Dis-
parity among the results of these adult
studies and our data could be related to
age,maturationalstage,adipositystate,or
number of participants studied.
In conclusion, our study demon-
strates that African American adolescents
are not more susceptible to FFA-induced
insulin resistance than Caucasian youth.
Data on long-term elevations in FFA con-
centrations in adolescents, induced by
prolonged lipid-rich diets, are needed to
assessanelevation’sfullimpactoninsulin
resistance. It also remains to be deter-
mined whether the increased insulin se-
cretion previously reported in healthy
African American youth (10,19) is a stim-
ulatory phenomenon of FFA on the
	-cell.
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